about
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarctionStatin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort studyMissing Oral Health-Related Data in the interRAI-HC - Associations with Selected Variables of General Health and the Effect of Multiple Imputation on the Relationship between Oral and General Health.Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS dataEstimating local and global measures of association for bivariate interval censored data with a smooth estimate of the density.Modeling the association of bivariate interval-censored data using the copula approach.The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialMiddle ear cholesteatoma: non-echo-planar diffusion-weighted MR imaging versus delayed gadolinium-enhanced T1-weighted MR imaging--value in detection.Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary InterventionST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves.How do cumulative live birth rates and cumulative multiple live birth rates over complete courses of assisted reproductive technology treatment per woman compare among registries?The value of a baseline caries risk assessment model in the primary dentition for the prediction of caries incidence in the permanent dentition.Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.Dental attendance in preschool children - a prospective study.The history of Belgian assisted reproduction technology cycle registration and control: a case study in reducing the incidence of multiple pregnancy.Effects of electrical stimulation or lesion in nucleus accumbens on the behaviour of rats in a T-maze after administration of 8-OH-DPAT or vehicle.Anxiety and depression in the first six months after stroke. A longitudinal multicentre study.Sense of coherence and perceived physical health explain the better quality of life in adolescents with congenital heart disease.Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomiPrevalence and determinants of enamel fluorosis in Flemish schoolchildren.The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention.Bacteriology testing of cardiovascular tissues: comparison of transport solution versus tissue testing.Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New TreatmentReperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysisDrug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.Contribution of four common pulmonary function tests to diagnosis of patients with respiratory symptoms: a prospective cohort study.Reply: the danger of ignoring pregnancy and delivery rates in ART.Evaluation of 6 years of confidential unit exclusion at the Belgian Red Cross Flanders Blood Service.Short-term reproducibility of pressure pain thresholds in masticatory muscles measured with a new algometer.The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study.Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.Stroke rehabilitation in Europe: what do physiotherapists and occupational therapists actually do?Use of time by stroke patients: a comparison of four European rehabilitation centers.Dynamic 68Ga-DOTATOC PET/CT and static image in NET patients. Correlation of parameters during PRRT.Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.Determination of residual dimethylsulfoxide in cryopreserved cardiovascular allografts.Effect evaluation of an oral health promotion intervention in preschool children.Reply: Legislation of embryo transfer affected the denominator, not the numerator!
P50
Q28168974-A306A740-CA07-4348-A67A-0D5C796CE73DQ28732032-BED11482-1511-4AE4-B4B1-96A5E9FD6557Q31034444-590BEAB3-1EA7-44F5-8A8E-6DFC167145D2Q31039791-1D746464-847E-41FD-876A-6CFFC66046E4Q33351402-B2983012-A27C-40DF-8887-92480AB8DF93Q33372828-426CCA34-FA3E-479C-89EC-97EDE6D7FA0FQ36763617-85BB64D7-2809-42C5-A2FD-4A52980B4815Q37760655-769E1898-6F2D-4B8E-BC77-B7324E27D065Q38372507-3AA33297-9AEE-4A71-8658-29CDE5F607D9Q38424567-87B955BE-C32F-4C06-A291-B2803DBEB8F4Q38724104-F51104E2-6C9B-4860-9864-E6D3C2005182Q39876873-EEA642D5-C1F1-407C-8171-15D35706EACFQ40355090-DF108904-C908-424F-BAB5-F6BAF310E8AAQ40665728-F1FE3017-1975-45EF-BC20-4D9CEC921BDBQ41507036-AC866F8D-AF9D-4CFF-9FCD-32E149819FD2Q44254990-1ECF472F-A0DB-4E2C-BD70-637114D6D7ACQ44285036-A663F822-D466-47B4-B76C-7A02247EF6AAQ44366977-27835317-4C01-4F90-AAA8-FD1C385F83ACQ44439576-93B139D0-83A1-4E2C-B3D2-D1DEF2FC5059Q44463562-63904028-5789-4BFD-80F0-99493939871FQ44504043-76E94146-9129-428B-8570-F2F87CE36BB4Q44667423-C64B6083-61D9-466A-B20F-395A380E0BC9Q44671355-17F72B6A-2688-4B8D-9AC3-EA00F21AFB36Q46624593-31375F74-1941-4473-A691-5365D75190F9Q48332592-ACC05CA3-3816-4B5A-972C-FC042894903FQ48531429-3E1B0298-53C2-42B2-82DA-5EA4AFC5D73BQ48611685-64C22847-3605-4DC8-AD5B-6E75884527B8Q49094350-55523CD7-9483-4FE7-8151-BAA79277C5BDQ49167603-77DBA564-F8B5-40C3-A8E9-359A52F12EB6Q50482887-0ED39379-4DB3-45AC-ABC7-5FA6124B03D6Q50861652-9EE32B86-4CA6-4576-A282-C04868670DD3Q50900033-F0277FA9-1388-4D5B-8B02-CCF63475985BQ51242700-FCCE940A-8808-4969-92B3-166D73A472EAQ51942838-A7EA0271-7545-498C-AA72-BD5E21779ECDQ51967540-647986B3-22C4-4F13-95E2-0B1225A2A89DQ52983806-1CC7B512-A128-4E2E-9076-C67D6A4D3F8CQ52997708-CF1AD94D-DE8D-400D-931A-7A148B27BA63Q53536770-C622DD78-D403-4D2A-921F-EF5E906CD4E9Q54401201-8A40913F-3EEE-4EAA-BFA0-CDE037FF64A0Q54528426-C0CDB0AD-3581-4489-A0E8-07A306DAF35C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kris Bogaerts
@ast
Kris Bogaerts
@en
Kris Bogaerts
@es
Kris Bogaerts
@nl
Kris Bogaerts
@sl
type
label
Kris Bogaerts
@ast
Kris Bogaerts
@en
Kris Bogaerts
@es
Kris Bogaerts
@nl
Kris Bogaerts
@sl
prefLabel
Kris Bogaerts
@ast
Kris Bogaerts
@en
Kris Bogaerts
@es
Kris Bogaerts
@nl
Kris Bogaerts
@sl
P106
P21
P31
P496
0000-0003-0188-8665
P569
2000-01-01T00:00:00Z